Greenlight photoselective 120-Watt 532-nm lithium triborate laser vaporization prostatectomy in living canines

Journal of Endourology

Volumn 23, Issue 5, 2009, Pages 837-845

  Malek, Reza S ^a   Kang, Hyun Wook ^b   Coad, James E ^c   Koullick, Ed ^d  

^a MAYO CLINIC   (United States)

^b Innovation Center   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

^d American Medical Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM DERIVATIVE; LITHIUM TRIBORATE; POTASSIUM DERIVATIVE; POTASSIUM TITANYL PHOSPHATE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG; LITHIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DOG; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LASER PROSTATECTOMY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE DISEASE; SURVIVAL RATE; TRANSRECTAL ULTRASONOGRAPHY; ANIMAL; DOG; LIGHT; LOW LEVEL LASER THERAPY; METHODOLOGY; PATHOLOGY; POSTOPERATIVE CARE; PROSTATE; PROSTATECTOMY;

ANIMALS; DOGS; LASER THERAPY; LIGHT; LITHIUM; MALE; POSTOPERATIVE CARE; PROSTATE; PROSTATECTOMY;

EID: 67649882325     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0669     Document Type: Article

References (13)

1. Malek RS. Photoselective KTP laser vaporization of obstructive BPH (PVP). In: Recent Advances in Endouro-logy 8: Interventional Management of Urological Diseases. Baba S, Ono Y, eds. Tokyo: Springer-Verlag, 2006, pp. 103-122.
2. Malek RS. GreenLight" HPS Laser Therapy for BPH. Clinical outcomes and surgical recommendations from the International GreenLight User (IGLU) Group. Eur Urol 2008;7(suppl):361-362.
3. Kang HW, Jebens D, Malek RS, Mitchell G, Koullick E. Laser vaporization of bovine prostate: A quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers. J Urol 2008;180:2675-2680.
4. Malek RS, Barrett DM, Kuntzman RS. High-power potassium-titanyl-phosphate (KTP/532) laser vaporization prostatectomy: 24 hours later. Urology 1998;51:254-256.
5. Te AE, Malloy TR, Stein BS, Ulchaker JC, Nseyo UO, Hai MA, Malek RS. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12-month results from the first United States multicenter prospective trial. J Urol 2004;172:1404-1408.
6. Malek RS, Kuntzman RS, Barrett DM. Photoselective potassium-titanyl- phosphate laser vaporization of the benign obstructive prostate: Observations on long-term outcomes. J Urol 2005;174:1344-1348.
7. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-1159.
8. Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100mL. BJU Int 2007;100:593-598.
9. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. Potassium-titanyl- phosphate laser vaporization of the prostate: A comparative functional and pathologic study in canines. Urology 1996;48:575-583.
10. Kuntzman RS, Malek RS, Barrett DM, Bostwick DG. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers. Urology 1997;49:703-708.
11. Thomsen SL, Coad JE. Developing clinically successful biomedical devices by understanding the pathophysiology of the target tissue: Insights from over 25 years at the microscope. Proc SPIE 2007;6440:1-15.
12. Woo H, Reich O, Bachmann A, Choi B, Collins E, de la Rosette J, et al. Outcome of GreenLight HPS 120-W laser therapy in specific patient populations: Those in retention, on anticoagulants, and with large prostates (≥80mL). Eur Urol 2008;7(suppl):378-383.
13. Kabalin JN. Holmium-YAG laser prostatectomy canine feasibility study. Lasers Surg Med 1996;18:221-224.